Cardlytics (CDLX) Tops Q1 EPS by 13c
Cardlytics (NASDAQ: CDLX) reported Q1 EPS of ($0.23), $0.13 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $36 million versus the consensus estimate of $36.11 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
